Aurel Toma1, Barbara E Stähli2, Michael Gick1, Miroslaw Ferenc1, Kambis Mashayekhi1, Heinz Joachim Buettner1, Franz-Josef Neumann1, Catherine Gebhard3,4. 1. Division of Cardiology and Angiology II, University Heart Center Freiburg, Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany. 2. Department of Cardiology, Charité Berlin, University Medicine, Campus Benjamin Franklin, Berlin, Germany. 3. Division of Cardiology and Angiology II, University Heart Center Freiburg, Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany. Catherine.Gebhard@universitaets-herzzentrum.de. 4. Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland. Catherine.Gebhard@universitaets-herzzentrum.de.
Abstract
OBJECTIVE: Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) has undergone impressive progress during the last decade, both in strategies and equipment. It is unknown whether technical refinement has translated into improved outcomes in women undergoing CTO-PCI. METHOD AND RESULTS: A total of 2002 consecutive patients (17% females, mean age 65.2 ± 10.7 years) undergoing PCI of at least one CTO lesion at our center between 01/2005 and 12/2013 were evaluated. The incidence of adverse events was compared between two time series (2005-2009 and 2010-2013). A significant increase in adverse lesion characteristics over time was noted in both, women and men (p < 0.001), while technical success rates significantly increased in men but not in women (ptrend < 0.001 in men and ptrend=0.9 in women). The incidence of procedural complications was significantly higher in women as compared to men and increased over the study period in women (p < 0.05) but not in men. Accordingly, multivariate logistic regression analysis identified female sex as a strong predictor of PCI-related complications in recent years, while this was not the case in earlier years (adjusted HR 2.03, 95% CI 0.62-6.6, p = 0.2 and adjusted HR 4.7, 95% CI 1.8-12.3, p = 0.002, respectively, p < 0.001 for log LH ratio). In addition, major adverse cardiovascular events (MACE) after a 3-year follow-up significantly declined in men (log rank = 0.046), while no changes were observed in women. CONCLUSION: While higher success rates and a reduced rate of MACE have been achieved in men, the incidence of procedural complications in women undergoing CTO-PCI has increased over time.
OBJECTIVE: Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) has undergone impressive progress during the last decade, both in strategies and equipment. It is unknown whether technical refinement has translated into improved outcomes in women undergoing CTO-PCI. METHOD AND RESULTS: A total of 2002 consecutive patients (17% females, mean age 65.2 ± 10.7 years) undergoing PCI of at least one CTO lesion at our center between 01/2005 and 12/2013 were evaluated. The incidence of adverse events was compared between two time series (2005-2009 and 2010-2013). A significant increase in adverse lesion characteristics over time was noted in both, women and men (p < 0.001), while technical success rates significantly increased in men but not in women (ptrend < 0.001 in men and ptrend=0.9 in women). The incidence of procedural complications was significantly higher in women as compared to men and increased over the study period in women (p < 0.05) but not in men. Accordingly, multivariate logistic regression analysis identified female sex as a strong predictor of PCI-related complications in recent years, while this was not the case in earlier years (adjusted HR 2.03, 95% CI 0.62-6.6, p = 0.2 and adjusted HR 4.7, 95% CI 1.8-12.3, p = 0.002, respectively, p < 0.001 for log LH ratio). In addition, major adverse cardiovascular events (MACE) after a 3-year follow-up significantly declined in men (log rank = 0.046), while no changes were observed in women. CONCLUSION: While higher success rates and a reduced rate of MACE have been achieved in men, the incidence of procedural complications in women undergoing CTO-PCI has increased over time.
Entities:
Keywords:
Chronic total occlusion; Percutaneous coronary intervention; Temporal trend; Women
Authors: Georgios Sianos; Gerald S Werner; Alfredo R Galassi; Michail I Papafaklis; Javier Escaned; David Hildick-Smith; Evald Høj Christiansen; Anthony Gershlick; Mauro Carlino; Angelos Karlas; Nikolaos V Konstantinidis; Salvatore D Tomasello; Carlo Di Mario; Nicolaus Reifart Journal: EuroIntervention Date: 2012-05-15 Impact factor: 6.534
Authors: Vinoda Sharma; William Wilson; William Smith; Margaret McEntegart; Keith Oldroyd; Novalia Sidik; Alan Bagnall; Mohaned Egred; John Irving; Julian Strange; Thomas Johnson; Simon Walsh; Colm Hanratty; James Spratt Journal: Am J Cardiol Date: 2016-11-16 Impact factor: 2.778
Authors: Claire S Duvernoy; Dean E Smith; Prerana Manohar; Ann Schaefer; Eva Kline-Rogers; David Share; Richard McNamara; Hitinder S Gurm; Mauro Moscucci Journal: Am Heart J Date: 2010-04 Impact factor: 4.749
Authors: Bimmer E Claessen; Alaide Chieffo; George D Dangas; Cosmo Godino; Seung-Whan Lee; Kotaro Obunai; Mauro Carlino; Vaso Chantziara; Irini Apostolidou; José P S Henriques; Martin B Leon; Carlo Di Mario; Seung-Jung Park; Gregg W Stone; Jeffrey W Moses; Antonio Colombo; Roxana Mehran Journal: J Invasive Cardiol Date: 2012-10 Impact factor: 2.022
Authors: Winthrop D Piper; David J Malenka; Thomas J Ryan; Samuel J Shubrooks; Gerald T O'Connor; John F Robb; Karen L Farrell; Mary S Corliss; Michael J Hearne; Mirle A Kellett; Matthew W Watkins; William A Bradley; Bruce D Hettleman; Theodore M Silver; Paul D McGrath; John R O'Mears; David E Wennberg Journal: Am Heart J Date: 2003-06 Impact factor: 4.749
Authors: Martin Geyer; Johannes Wild; Marc Hirschmann; Zisis Dimitriadis; Thomas Münzel; Tommaso Gori; Philip Wenzel Journal: J Clin Med Date: 2020-01-09 Impact factor: 4.241
Authors: Zbigniew Siudak; Leszek Bryniarski; Krzysztof Piotr Malinowski; Wojciech Wańha; Wojciech Wojakowski; Sławomir Surowiec; Robert Balan; Sławomir Januszek; Artur Pawlik; Natalia Siwiec; Krzysztof Bryniarski; Andrzej Surdacki; Jacek Legutko; Krzysztof Bartuś; Stanisław Bartuś; Rafał Januszek Journal: J Clin Med Date: 2022-03-04 Impact factor: 4.241